These results show that the CXCL13-CXCR5 axis is involved in the crosstalk between chemokines and cell growth during the development of colorectal carcinogenesis, which provides a therapeutic strategy for targeting CXCL13/CXCR5 in the future clinical treatment of colorectal cancer. The gene discussed is CXCR5; the disease is colorectal cancer.